| Name | International Biotech Trust |
|---|---|
| Epic | IBT |
| Isin | GB0004559349 |
| Index | MID300 |
| Industry | Closed End Investments |
| Latest share price | 694.00p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £248.93 | Debt ratio | n/a |
| Shares in issue | 36.28 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | 28.40p | Price to book value | n/a |
| Dividend yield | 4.2 | ROCE | n/a |
| Dividend cover | -0.32 | EPS growth | n/a |
| Earning per share | -9.16 | 52-week high / low | 604.00p / 726.00p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| 2nd Interim | 2024-07-25 | 2024-08-23 | 14.50p |
| 1st Interim | 2023-12-21 | 2024-01-26 | 13.90p |
| 2nd Interim | 2023-07-27 | 2023-08-25 | 14.20p |
| 1st Interim | 2022-12-29 | 2023-01-27 | 14.00p |
| 2nd Interim | 2022-08-04 | 2022-08-26 | 15.70p |
| 1st Interim | 2021-12-30 | 2022-01-28 | 15.70p |
| 2nd Interim | 2021-07-15 | 2021-08-27 | 14.20p |
| 1st Interim | 2020-12-24 | 2021-01-29 | 14.20p |
| 2nd Interim | 2020-07-16 | 2020-08-28 | 12.40p |
| Company name | International Biotech Trust |
|---|---|
| Address | 6th Floor, 65 Gresham Street, London, England, United Kingdom, EC2V 7NQ |
| Telephone | +44 (0) 20 7410 5971 |
| Website | http://www.internationalbiotrust.com/ |
| Director | Position |
|---|---|
| Ms Gillian Elcock | Non-Executive Director |
| Ms Katherine Cornish-Bowden | Non-Executive Chairman |
| Mr Patrick Magee | Senior Independent Director |
| Mr Patrick Maxwell | Independent Non-Executive Director |
| Ms Caroline Gulliver | Independent Non-Executive Director |
| Assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Reporting date | 31/08/24 | 31/08/23 | 31/08/22 |
| Intangible asssets and goodwill | n/a | n/a | n/a |
| Investments and other non-current assets | 297.51 | 301.9 | 313.43 |
| Total non-current assets | 297.51 | 301.9 | 313.43 |
| Inventory / work in progress | n/a | n/a | n/a |
| Trade and other receivables | 0.22 | 2.97 | 13.49 |
| Cash and equivalents | 10.43 | n/a | n/a |
| Other current assets and asset held for resale | n/a | n/a | n/a |
| Total of all assets | 308.15 | 304.87 | 326.92 |
| Liabilities £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Short term liabilities | 25.89 | 34.55 | 42.03 |
| Long term liabilities | n/a | n/a | n/a |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 25.89 | 34.55 | 42.03 |
| Net assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net assets | 282.27 | 270.32 | 284.89 |
| Equity £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Share capital | 10.35 | 10.35 | 10.35 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | n/a | n/a | -46.66 |
| Share premium account | 29.87 | 29.87 | 29.87 |
| Total equity | 282.27 | 270.32 | 284.89 |
| Income £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -1.16 | -2.51 | -2.11 |
| Pre-tax profit | -3.36 | -3.75 | -2.78 |